[Comorbid gastric and duodenal changes in chronic hepatitis C in young patients]

Insights

Young patients with chronic hepatitis C often have latent stomach and duodenal issues, frequently linked to Helicobacter pylori (HP). Eradicating HP is generally not recommended for these patients.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic hepatitis C (CHC) can affect the upper gastrointestinal tract.
  • Helicobacter pylori (HP) is a common pathogen with known gastrointestinal effects.
  • Understanding coinfections and comorbidities in CHC is crucial for patient management.

Purpose of the Study:

  • To investigate the characteristics of the gastroduodenal zone in young CHC patients.
  • To determine the frequency of gastric mucosa contamination with HP in this population.
  • To assess the impact of upper gastroduodenal affections on CHC progression.

Main Methods:

  • Study population: Young patients diagnosed with chronic hepatitis C.
  • Assessment of gastroduodenal affections through clinical evaluation and potentially endoscopic procedures.
  • Diagnostic testing for Helicobacter pylori infection in the gastric mucosa.

Main Results:

  • A high prevalence (76.3%) of gastroduodenal affections was observed in young CHC patients.
  • These affections were often latent and associated with HP in a majority of cases (80%).
  • Concurrent upper gastroduodenal diseases had minimal impact on the course of HCV infection.

Conclusions:

  • Latent gastroduodenal affections, often HP-related, are common in young patients with CHC.
  • The clinical significance of these coinfections on HCV progression appears limited.
  • Avoidance of HP eradication is suggested for young CHC patients to prevent unnecessary interventions.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...